Xsensio is developing Lab-on-Skin, a platform of wearable biosensors that continuously measure biochemical biomarkers. The company is raising USD 7 million in a Series A led by WI Harper to accelerate its clinical validation.
- Announced on
- Round
- Series A
- Amount
- USD 7 M
- Location
- Lausanne, canton of Vaud
- Sector
- Health & medtech, Deep tech
Investors
- WI Harper lead
- Privilège Ventures
- European Innovation Council
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic